Home » Newsletters » BioWorld

BioWorld

Dec. 23, 1992

View Archived Issues

GENZYME GRANTED TWO PATENTS

SCICLONE RESTRUCTURES SINGAPORE VENTURE

PIGS POTENTIAL HUMAN ORGAN DONORS

APBI EARNINGS LOWER THAN EXPECTED

PROCYTE PACT WITH KAKEN

CONSORTIUM GETS MATCHING GRANT

BIO-INTERFACES SELLS LIFECORE SHARES

CAMBRIDGE BIOTECH LICENSES TB TEST TECHNOLOGY

VESTAR TO CO-DEVELOP RADIOTHERAPY

STEM CELL TECHNOLOGY VS. CANCER

THERATECH UNDERWRITERS EXERCISE OPTION

AMERICAN BIOGENETIC LICENSING PACT

BIOMERICA DEVELOPS ELISA TEST

CURATIVE GETS PATENT

BIOJECT BECOMES SUBSIDIARY

COLLABORATIVE GETS SBIR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...